Befejeződött1. fázis
A Phase 1, Dose-Escalating, Randomized, Placebo-Controlled, 4-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of COR-1167 in Healthy Subjects and Subjects with Chronic Heart Failure (CHF)
Key facts
- Where
- Deventer, Groningen, Sneek és Venlo, HollandiaSee the 4 sites
- Phase
- 1. fázis
Where in Hollandia
- Deventer ZiekenhuisDeventer, HollandiaNo longer taking part
- Pharmaceutical Research Associates Group B.V.Groningen, HollandiaNo longer taking part
- D & A Research B.V.Sneek, HollandiaNo longer taking part
- Stichting Viecuri Medisch Centrum voor Noord-LimburgVenlo, HollandiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Corteria Pharmaceuticals
- Trial code
- EU 2023-508543-42-00
- Record updated
- 2026. március 5.